Navigation Links
FDA Grants 510(k) Clearance for Innovative Fuse Gastroscope from EndoChoice
Date:10/28/2013

ATLANTA, Oct. 28, 2013 /PRNewswire/ -- Now doctors performing flexible endoscopy have a new tool available to help them see more anatomy and facilitate diagnoses in the upper GI tract. Traditional gastroscopes that have been available to endoscopists provide a field of view limited to about 140 degrees. EndoChoice® today announced the FDA had provided 510(k) clearance of its new Fuse™ Gastroscope that has a field of view of 245 degrees. Endoscopes are thin flexible tubes with imaging capabilities that doctors use to view the upper and lower GI tracts of their patients.

EndoChoice engineers have developed a proprietary, new method of designing and manufacturing flexible circuits that allow them to put more small cameras on the tips of flexible endoscopes. This new concept of Full Spectrum Endoscopy™ is changing the field of endoscopy where significant improvements in technology have not occurred in more than 20 years. The new gastroscope joins the revolutionary, endoscopy system line of products released earlier this year by EndoChoice under the Fuse brand. The Fuse Gastroscope has two cameras and the Fuse Colonoscope has three cameras while traditional systems have just one camera.

The Fuse system allows doctors to see nearly twice as much surface area as they can with traditional endoscopes. Because of the folds that occur naturally in the colon and stomach anatomy, problem areas can easily go undetected when using traditional endoscopes. The Fuse system allows GI doctors to see into and behind those folds. The images of the anatomy are displayed on high-definition screens specially arranged to give the doctor a full spectrum view.

Data supporting the Fuse system were presented simultaneously at the American College of Gastroenterology Annual Scientific Session last week in San Diego, California, and at the Union European Gastroenterology Week in Berlin, Germany. Researchers demonstrated the ability to see more with the Fuse system has a statistically significant impact on their ability to find adenomas or precancerous lesions when compared to traditional single-view endoscopes. "We have a national colorectal cancer screening program in the United States wherein most people should get screened for colorectal cancer, but not all patients follow these guidelines. The data from the Full Spectrum Endoscopy Tandem study would indicate that Fuse is a radical improvement over the tools we've used in the past to fight GI disease," said Douglas K. Rex, Professor of Medicine at Indiana University.

"We are 100% focused on serving the GI professionals so they can give the best possible care to their patients," said Mark Gilreath, Founder and CEO at EndoChoice. "This clearance by the FDA is yet another milestone in our efforts to make the Fuse system available to more hospitals and clinics."

About EndoChoice

Based in Atlanta, EndoChoice is a platform GI company that provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal diseases. EndoChoice currently has over 2,000 customers and distribution in 34 countries worldwide, and has been recognized for four consecutive years as one of the fastest growing companies in the U.S. by Inc. Magazine. To learn more, visit www.endochoice.com.

EndoChoice and Fuse™ are trademarks of EndoChoice, Inc

For more information, press only:

Doug Ladd, Chief Marketing Officer
513-608-6873 or Doug.Ladd@endochoice.com

For more information on Fuse™

www.endochoice.com/fuse


'/>"/>
SOURCE EndoChoice
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Philanthropic Grants, Product Launches, Promising Partnerships, and Customer Satisfaction Rankings - Research Report on CVS Caremark, Walgreens, McKesson, AmerisourceBergen, and Cardinal Health
2. Life Technologies Awards Digital PCR Innovation Grants to Five Research Labs
3. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
4. FDA Grants Orphan Drug Designation to Omeros OMS824 for Huntingtons Disease
5. European Union Grants a Good Manufacturing Practice Certificate to Nelson Laboratories
6. The Kenneth Rainin Foundation Continues its Commitment to Ending Inflammatory Bowel Disease, Awarding $1.5 Million in Research Grants
7. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
8. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
9. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
10. Agnitio Grants 10,000 New Licenses Globally this Financial Year
11. FDA Grants Soligenix "Fast Track" Designation for SGX942 for the Treatment of Oral Mucositis in Patients with Head and Neck Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
(Date:6/23/2016)... June 23, 2016 Research and ... Procedure Volumes: Global Analysis (United States, China, Japan, Brazil, ... report to their offering. ... for healthcare business planners, provides surgical procedure volume data ... trends with an in-depth analysis of growth drivers and ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):